Tag: Cancer research
David Epstein launches new cancer startup after Novartis and Seagen career
David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop...
Biden’s ‘Moonshot’ Initiative: Reducing Cancer Deaths in Final Months of Office
President Joe Biden is focusing on his administration's "moonshot" initiative to reduce cancer deaths as he nears the end of his term. He plans...
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly),...
The Cost of Cancer Screening: A $43 Billion Annual Expense
The United States spends a significant amount of money on cancer screening each year, with estimates showing that $43 billion was spent in 2021...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
